Agnieszka Boesen

Array ( [id] => 8227310 [patent_doc_number] => 20120141519 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-06-07 [patent_title] => 'REAGENTS AND METHODS FOR DETECTING INFLUENZA VIRUS PROTEINS' [patent_app_type] => utility [patent_app_number] => 13/322459 [patent_app_country] => US [patent_app_date] => 2010-05-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 6854 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13322459 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6392306 [patent_doc_number] => 20100303847 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-12-02 [patent_title] => 'COMPOSITIONS OF TOLL-LIKE RECEPTOR AGONISTS AND PAPILLOMAVIRUS ANTIGENS AND METHODS OF USE THEREOF' [patent_app_type] => utility [patent_app_number] => 12/787649 [patent_app_country] => US [patent_app_date] => 2010-05-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 24 [patent_figures_cnt] => 24 [patent_no_of_words] => 22170 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0303/20100303847.pdf [firstpage_image] =>[orig_patent_app_number] => 12787649 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8184144 [patent_doc_number] => 20120114661 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-05-10 [patent_title] => 'METHODS OF IDENTIFYING INFECTIOUS DISEASE AND ASSAYS FOR IDENTIFYING INFECTIOUS DISEASE' [patent_app_type] => utility [patent_app_number] => 13/322232 [patent_app_country] => US [patent_app_date] => 2010-05-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 17153 [patent_no_of_claims] => 58 [patent_no_of_ind_claims] => 45 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13322232 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6134356 [patent_doc_number] => 20110008280 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-01-13 [patent_title] => 'METHODS FOR TREATING VIRAL INFECTION USING IL-28 AND IL-29 CYSTEINE MUTANTS' [patent_app_type] => utility [patent_app_number] => 12/784407 [patent_app_country] => US [patent_app_date] => 2010-05-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 39456 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0008/20110008280.pdf [firstpage_image] =>[orig_patent_app_number] => 12784407 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6589120 [patent_doc_number] => 20100291606 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-11-18 [patent_title] => 'SCREENING SYSTEM FOR DETECTING INHIBITORS OF HIV INTEGRASE-LEDGF/p-75 INTERACTION' [patent_app_type] => utility [patent_app_number] => 12/779154 [patent_app_country] => US [patent_app_date] => 2010-05-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 8021 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0291/20100291606.pdf [firstpage_image] =>[orig_patent_app_number] => 12779154 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5952220 [patent_doc_number] => 20110033389 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-02-10 [patent_title] => 'Modified antibodies for passive immunotherapy' [patent_app_type] => utility [patent_app_number] => 12/799746 [patent_app_country] => US [patent_app_date] => 2010-04-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 54915 [patent_no_of_claims] => 53 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0033/20110033389.pdf [firstpage_image] =>[orig_patent_app_number] => 12799746 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6617255 [patent_doc_number] => 20100310656 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-12-09 [patent_title] => 'Immunotherapy and prevention of autoimmune hepatitis' [patent_app_type] => utility [patent_app_number] => 12/662663 [patent_app_country] => US [patent_app_date] => 2010-04-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12756 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0310/20100310656.pdf [firstpage_image] =>[orig_patent_app_number] => 12662663 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8185303 [patent_doc_number] => 20120115207 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-05-10 [patent_title] => 'ENHANCED PRODUCTION OF PAPILLOMAVIRUS-LIKE PARTICLES WITH A MODIFIED BACULOVIRUS EXPRESSION SYSTEM' [patent_app_type] => utility [patent_app_number] => 13/257248 [patent_app_country] => US [patent_app_date] => 2010-03-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 6705 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0115/20120115207.pdf [firstpage_image] =>[orig_patent_app_number] => 13257248 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6477503 [patent_doc_number] => 20100285055 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-11-11 [patent_title] => 'Activation of natural killer (NK) cells and methods of use' [patent_app_type] => utility [patent_app_number] => 12/661636 [patent_app_country] => US [patent_app_date] => 2010-03-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 16224 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0285/20100285055.pdf [firstpage_image] =>[orig_patent_app_number] => 12661636 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6454891 [patent_doc_number] => 20100189742 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-07-29 [patent_title] => 'HPV epitopes targeted by T cells infiltrating cervical malignancies for use in vaccines' [patent_app_type] => utility [patent_app_number] => 12/592528 [patent_app_country] => US [patent_app_date] => 2010-02-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 20845 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0189/20100189742.pdf [firstpage_image] =>[orig_patent_app_number] => 12592528 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10844055 [patent_doc_number] => 08871226 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-10-28 [patent_title] => 'Methods and compositions for the treatment and diagnosis of cancer' [patent_app_type] => utility [patent_app_number] => 12/689658 [patent_app_country] => US [patent_app_date] => 2010-01-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 36 [patent_figures_cnt] => 36 [patent_no_of_words] => 9230 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 123 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12689658 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8908986 [patent_doc_number] => 08481045 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-07-09 [patent_title] => 'Immunogenic protein constructs' [patent_app_type] => utility [patent_app_number] => 12/687653 [patent_app_country] => US [patent_app_date] => 2010-01-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 13309 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 79 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12687653 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6582287 [patent_doc_number] => 20100129901 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-05-27 [patent_title] => 'HEPATITIS C VIRUS VACCINE' [patent_app_type] => utility [patent_app_number] => 12/633104 [patent_app_country] => US [patent_app_date] => 2009-12-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 92 [patent_figures_cnt] => 92 [patent_no_of_words] => 22342 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12633104 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6431182 [patent_doc_number] => 20100143378 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-06-10 [patent_title] => 'Subcutaneous Administration of Anti-Hepatitis B Antibodies' [patent_app_type] => utility [patent_app_number] => 12/630433 [patent_app_country] => US [patent_app_date] => 2009-12-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 11240 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0143/20100143378.pdf [firstpage_image] =>[orig_patent_app_number] => 12630433 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6425832 [patent_doc_number] => 20100151492 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-06-17 [patent_title] => 'METHODS FOR THE TREATMENT OF INFECTIONS AND TUMORS' [patent_app_type] => utility [patent_app_number] => 12/626848 [patent_app_country] => US [patent_app_date] => 2009-11-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 43 [patent_figures_cnt] => 43 [patent_no_of_words] => 67282 [patent_no_of_claims] => 52 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0151/20100151492.pdf [firstpage_image] =>[orig_patent_app_number] => 12626848 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6500238 [patent_doc_number] => 20100215662 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-08-26 [patent_title] => 'Anti-influenza M2e antibody' [patent_app_type] => utility [patent_app_number] => 12/592241 [patent_app_country] => US [patent_app_date] => 2009-11-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 16098 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0215/20100215662.pdf [firstpage_image] =>[orig_patent_app_number] => 12592241 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10505288 [patent_doc_number] => 09233148 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-01-12 [patent_title] => 'Replikin-based compounds for prevention and treatment of influenza and methods of differentiating infectivity and lethality in influenza' [patent_app_type] => utility [patent_app_number] => 12/581112 [patent_app_country] => US [patent_app_date] => 2009-10-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 53076 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 165 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12581112 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8683932 [patent_doc_number] => 20130052215 [patent_country] => US [patent_kind] => A9 [patent_issue_date] => 2013-02-28 [patent_title] => 'TUMOR VACCINE' [patent_app_type] => utility [patent_app_number] => 12/580554 [patent_app_country] => US [patent_app_date] => 2009-10-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 18680 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12580554 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8683932 [patent_doc_number] => 20130052215 [patent_country] => US [patent_kind] => A9 [patent_issue_date] => 2013-02-28 [patent_title] => 'TUMOR VACCINE' [patent_app_type] => utility [patent_app_number] => 12/580554 [patent_app_country] => US [patent_app_date] => 2009-10-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 18680 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12580554 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7783923 [patent_doc_number] => 20120045479 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-02-23 [patent_title] => 'Dry Powder Formulations, Vaccines and Methods' [patent_app_type] => utility [patent_app_number] => 13/124701 [patent_app_country] => US [patent_app_date] => 2009-10-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 4146 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0045/20120045479.pdf [firstpage_image] =>[orig_patent_app_number] => 13124701 [rel_patent_id] =>[rel_patent_doc_number] =>)